CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corporation (NASDAQ: GENZ) announced today that its genetic testing laboratory located in Phoenix, Arizona, has obtained the CAP 15189SM Accreditation to the International Standards Organization 15189:2007 Standard for laboratories from the College of American Pathologists. This accreditation recognizes the laboratory’s technical competence and continual quality management and underscores Genzyme’s commitment to improved patient outcomes by providing reliable test results.
